Hjem › Lungekreft › Ohio › Toledo
Kliniske studier for Lungekreft i Toledo, OH
11 studier for Lungekreft søker deltakere på steder i og rundt Toledo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Health - Saint Vincent Hospital, Toledo
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health Sylvania Radiation Oncology Center, Toledo
- og 1 flere
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruttererFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruttererFase 3
- Taylor Cancer Research Center, Maumee · 9 mi unna
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruttererFase 3
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi unna
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- ProMedica Flower Hospital, Sylvania · 9 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- ProMedica Flower Hospital, Sylvania · 9 mi unna
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- Taylor Cancer Research Center (site 204), Maumee · 9 mi unna
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RekruttererObservasjonsstudie
- Mercy Health St. Vincent Medical Center, Toledo
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Toledo
- Ikke-småcellet lungekreft17 studier
- Eggstokkreft12 studier
- Metastatisk kreft10 studier
- Slag9 studier
- Endometriekreft8 studier
- Melanom8 studier
- Pankreaskreft8 studier
- Plateepitelcancer i hode og hals8 studier
- Spiserørkreft7 studier
- Prostatakreft7 studier
- Hjertesvikt7 studier
- Kolorektal kreft7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.